FDA’s Marks Issues ‘Provocative’ Call To Set Target Gene Therapy Profile That Includes Costs

 
• By Sarah Karlin-Smith
gene therapy platforms are awesome (Shutterstock)

More from Cell & Gene Therapies

More from Pricing Debate